lobbying_activities: 1960165
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1960165 | d1bb8e6e-de08-44e2-9890-3ed4c6d9929c | Q1 | KING & SPALDING LLP | 21632 | U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM | 2017 | first_quarter | TOR | Provisions in the Food, Drug & Cosmetic Act related to advertising involving drugs | Congressional Budget Office (CBO) | 0 | 0 | 2017-04-19T12:49:29.610000-04:00 |